Renee Masi is a Managing Director at BioStar Ventures. She has more than 25 years of experience in the venture capital industry where she focused most recently on life science investing.

Ms. Masi currently serves on the boards of Autonomix, CardiacMD, and SynergEyes. Prior to joining BioStar Ventures, Ms. Masi was a Partner with Windward Ventures, a firm focused on southern California early-stage companies, where she was responsible for the firm’s life science investing strategy.

Ms. Masi was an advisor to Ventures Medical, a seed stage fund affiliated with the Texas Medical Center. In 1990, Ms. Masi opened the Boston office for Technology Funding, a $250 million venture capital fund based in San Mateo, California. She began her career as an investment banker in the healthcare finance group of Merrill Lynch. In addition to holding a BA from Stanford University and an MBA from The Wharton School of Business, Ms. Masi is also a member of the Board of Councilors for the USC Graduate School of Social Work.

Fund's investment verticals: cardiovascular and orthopedic medical.